Veletri

Veletri is a brand name of epoprostenol, approved by the FDA in the following formulation(s):

VELETRI (epoprostenol sodium - injectable; injection)

• 
  Manufacturer: ACTELION
  
  Approval date: June 27, 2008
  
  Strength(s): EQ 1.5MG BASE/VIAL ^[RLD]

Has a generic version of Veletri been approved?

No. There is currently no therapeutically equivalent version of Veletri available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Veletri. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Veletri.

See also...

• Veletri Consumer Information (Wolters Kluwer)
• Veletri Consumer Information (Cerner Multum)
• Veletri Advanced Consumer Information (Micromedex)
• Epoprostenol Consumer Information (Wolters Kluwer)
• Epoprostenol Consumer Information (Cerner Multum)
• Epoprostenol Intravenous Advanced Consumer Information (Micromedex)
• Epoprostenol Sodium AHFS DI Monographs (ASHP)